Articles tagged with Colon Cancer
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Researchers mapped the human genome for breast and colon cancers, finding that most cancer-causing gene mutations are diverse and vary from person to person. The study suggests that personalized medicine may focus on complex pathways linking less-commonly mutated genes.
Scientists at Johns Hopkins Medicine have developed a novel way to fight colorectal cancer using tiny molecules to deliver potent radiation inside cancer cells. The new system proved able to specifically target colon cancer cells, reducing unwanted side effects.
Scientists identify EphB2 and EphB3 receptors as key players in limiting tumor cell growth to confined compartments. This mechanism prevents tumors from invading other tissue areas.
A large study of European patients has identified promising biomarkers to distinguish between patients with a high likelihood and low likelihood of relapse, paving the way for more targeted treatment approaches.
The Fecal Immunochemical Test (FIT) detects human blood in the stool and has a high sensitivity of 81.8% for detecting colorectal cancers. FIT also has a higher specificity than traditional guaiac tests, reducing false positives and unnecessary procedures.
A new method of molecular profiling has accurately predicted which stage II colon cancer patients are most likely to have their disease recur after surgery. The analysis identified two groups with distinct clinical outcomes, allowing for more accurate selection of patients who would benefit from adjuvant chemotherapy.
A recent study published in the Journal of the National Cancer Institute found no strong association between fruit and vegetable intake and colon cancer risk. However, a lower risk of distal colon cancer was observed among those consuming high amounts of fruits and vegetables.
Researchers found that personalized interventions significantly improved colon cancer screening rates in primary care practices. Screening rates increased by 33-48% compared to usual care, with the most substantial improvements seen when personal messages addressed personal barriers to screening. The study suggests that a relatively si...
Researchers found that anthocyanins from purple corn, chokeberries, and bilberries can slow the growth of colon cancer cells. The compounds were tested on human colon cancer cells and rats with colon cancer, showing promising results. Further studies are needed to understand how these compounds interact with other food components.
A study found that patients with a diet high in meat, fat and refined grains had an increased risk of cancer recurrence and death compared to those with a diet rich in fruits and vegetables. The researchers identified two dietary patterns: prudent and Western, and found that the Western pattern was associated with a significant increas...
Researchers found that a Western diet was associated with a three-and-a-half times higher risk of colon cancer recurrence in patients who had undergone surgery and chemotherapy. In contrast, a prudent-pattern diet did not significantly influence cancer recurrence or mortality.
Researchers at Thomas Jefferson University found that colon cancer is caused by a lack of hormones that regulate intestinal epithelial cells. Hormone replacement therapy may prevent or treat the disease, shifting the focus from genetic to endocrine aspects.
Scientists have discovered that cancer cells eliminate the enzyme protein kinase G (PKG), leading to uncontrolled cell proliferation. Reintroducing PKG into cancer cells has been shown to inhibit tumor growth and angiogenesis, suggesting a potential new avenue for targeted cancer treatment.
Researchers developed a new drug delivery method using ultrasound to target cancer tumors, releasing chemotherapy drugs from nanobubbles. They found this approach was more effective at blocking tumor growth than other nanoparticle delivery methods. Vitamin D levels were also associated with reduced colon cancer risk in a separate study.
Researchers found a significant link between genetic variation on chromosome 8 and the risk of colorectal cancer, with individuals carrying the specific marker being 23% more likely to develop the disease. The study suggests that this single genetic variation might account for 14% of colorectal cancer cases in Israel.
Researchers at Michigan Medicine are studying the impact of a Mediterranean diet on colon cancer risk. The study will compare the diet with a standard healthy eating plan and investigate its effects on protein levels and antioxidant compounds in the body. Participants who complete the six-month study will receive $270.
Researchers at USC have identified specific molecular markers that may help predict tumor recurrence in stage II and III colon cancer patients. The study found that genes involved in angiogenesis pathway play a critical role in tumor relapse.
A predominantly Western diet high in red meat, fatty foods, refined grains, and desserts is associated with faster cancer recurrence and lower overall survival rate in stage III colon cancer patients. In contrast, a prudent diet rich in fruits, vegetables, poultry, and fish does not significantly influence cancer recurrence or mortality.
New studies examine factors that affect colonoscopy quality, including age, location, and technician training. Research suggests that competence in efficient colonoscopy requires more than 150 cases, with success rates improving significantly after this threshold.
Researchers at the University of Texas Medical Branch have developed a technique to close accidental colonoscopy wounds using small metal clips inserted through an endoscope. The new method has shown promising results in animal studies, with successful closure of perforations and reduced adhesions compared to surgical closure.
A colon cancer researcher outlines the benefits of aspirin in preventing colon cancer in high-risk individuals. Dr. Sanford Markowitz' editorial provides a roadmap for how medical science should employ aspirin and new aspirin-like drugs to decrease the risk of developing colon cancer.
Research highlights age-related risks for colon cancer patients undergoing surgery; obesity linked to increased polyp prevalence in women. Racial disparities also affect liver cancer treatment, with African Americans less likely to receive surgical therapy.
A recent study by Frederick H. Davidorf, MD, found that uveal melanoma patients and their families are at higher risk for developing colon cancer. The study involved 130 patients who provided their extended family medical histories, revealing a significant number of patients and relatives with an increased risk for colon cancer.
Recent advances in epidemiologic and experimental knowledge have validated health benefits of moderate coffee consumption. Studies suggest that moderate coffee drinking may reduce the risk of Parkinson's disease and Alzheimer's disease, while also lowering the risk of type 2 diabetes.
Researchers discovered compounds in black raspberries, blueberries, grape seeds, high-fiber foods, and apple juice that show promise for preventing cancer. Studies found significant reductions in tumors of the esophagus, colon, skin, and prostate cancers.
A study by Rutgers University and the US Department of Agriculture found that pterostilbene, a potent antioxidant in blueberries, reduced pre-cancerous lesions in rats with colon cancer by 57%. The compound also inhibited inflammation and cell proliferation.
Researchers at Thomas Jefferson University discovered a gene mutation that reduces the number of colon polyps, potentially cutting the risk of colon cancer. The Atp5a1 mutation is found in mice and has been linked to a significant decrease in polyp formation.
A systematic review of 17 studies found that increased lymph node evaluation is associated with improved survival rates for patients with stage II and III colon cancer. However, many patients do not receive adequate lymph node testing.
A study of 17 studies from nine countries found that removing and examining more lymph nodes during colon cancer surgery improves patient outcomes. The research suggests that knowing how far a cancer has spread leads to tailored treatment, ultimately resulting in better survival rates for patients.
A new study found that routine colonoscopic surveillance improves survival for colorectal cancer patients. Patients who underwent regular follow-up colonoscopies had better five-year survival rates compared to those who did not receive screenings.
A new immunochemical fecal occult blood test (I-FOBT) shows promise in increasing colon cancer screening rates by being more accurate and convenient than traditional methods. The test uses antibodies to detect human blood in stool, eliminating dietary restrictions and allowing for personalized positivity thresholds.
Researchers at Memorial Sloan-Kettering Cancer Center identified novel regulatory mechanisms of PTEN function. NEDD4-1 protein regulates PTEN stability by adding a molecular tag causing degradation. This finding provides a new therapeutic strategy, as proteasome inhibitors may selectively block degrading effects of ubiquitination.
Researchers at UT Southwestern Medical Center identified several genes whose expression is lost in lung, breast, prostate, and colon cancer. These findings could form the basis for a new early detection screen for certain cancers.
Since expanding screening coverage in 1998, the proportion of patients with colon cancer diagnosed at an early stage has increased. The study found that patients diagnosed during periods with universal coverage were significantly more likely to have early-stage illness than those diagnosed in earlier periods.
A recent study published in the Journal of Clinical Oncology suggests that postmenopausal women with colon cancer who used estrogen supplements within five years of diagnosis had a lower chance of dying from the disease. This finding may guide the development of safer colon cancer drugs.
A low-protein diet has been shown to have a greater protective effect against cancer than endurance exercise, independently of body fat mass. The study involved three groups of people and found significantly lower blood levels of plasma insulin-like growth factor 1 (IGF-1) in the low-protein diet group.
A new Italian risk model was found to be as accurate as a commonly used US model in predicting breast cancer diagnosis, suggesting the possibility of revising the model to include additional risk factors. Additionally, genetic variants have been linked to diarrhea when treated with certain cancer drugs, including gefitinib.
A multicenter study found that medium-sized colon polyps (0.6-0.9 cm) are associated with a significant number of advanced adenomas and cancers. This raises questions about the effectiveness of observational screening methods, which do not remove polyps.
Researchers are investigating the potential of nonsteroidal anti-inflammatory drugs (NSAIDs) to prevent various types of cancer, including colon, esophageal, and lung cancers. The studies focus on the preventive effects of sulindac, atorvastatin, and RaftiloseSynergy1 on cancer development.
Researchers at Children's Hospital Oakland Research Institute identified a specific enzyme called sphingosine phosphate lyase (SPL) that can cause the death of cancer cells. The study found that SPL makes cancer cells more vulnerable to chemotherapy, while removing the enzyme makes the cells more resistant to treatment.
Research reveals that obese patients are one-third more likely to experience cancer recurrence, while underweight patients face a doubled risk of death from non-cancer causes. The study suggests that excess weight can lead to reduced treatment efficacy due to concurrent illnesses.
A new study found that colon cancer patients with a body mass index of 35 kg/m² and higher had a significantly increased risk of cancer recurrence or death from colon cancer. Underweight patients, on the other hand, had a higher risk of death from non-colon cancer causes.
Scientists at the University of Texas Medical Branch discovered that blocking a single enzyme called aldose reductase can stop colon cancer cell growth. In mouse experiments, tumor progression was completely halted when human colon cancer cells were treated with genetic material that prevented the production of this enzyme.
Researchers developed an online questionnaire to predict an individual's chances of harboring mutations in genes linked to colon cancer. The tool is based on a five-year study of nearly 2,000 patients and can help healthcare providers identify at-risk patients for early screening.
A study by researchers at Fred Hutchinson Cancer Research Center found that regular aerobic exercise significantly reduces markers of increased colon-cancer risk in men. Men who exercised for four hours a week or more saw a significant decrease in cellular proliferation, which is associated with colon cancer.
Researchers at Johns Hopkins Kimmel Cancer Center have identified close to 200 mutated genes linked to breast and colon cancer. The genetic code reveals distinct pathways for the development of each cancer type, with some genes crucial for tumor formation. The findings provide a foundation for future comprehensive genetic studies.
A new study suggests that women with endometrial cancer should be screened for inherited Lynch syndrome mutations, which are associated with a high risk of several cancers. The study found that 1.8% of newly diagnosed endometrial cancer patients have these mutations, highlighting the importance of genetic screening and early detection.
People with colon cancer who engage in moderate exercise after therapy have a 50% higher survival rate than those who don't, according to Dana-Farber Cancer Institute research. Regular physical activity also reduces the risk of disease recurrence and mortality.
Stanford University researchers developed a 3D PET/CT imaging technique that provides a visual navigation of organs, allowing for better detection and characterization of cancer. The technology has potential for presurgical visualization, guiding biopsies and identifying tumor 'hot spots', enabling more precise diagnosis and treatment.
Eleven researchers received grants to accelerate the discovery and development of new agents for treating metastatic colon cancer. The study aims to identify mechanisms in colon cancer that make tumor cells resistant to apoptosis, as well as develop combination drug therapies to reverse the apoptotic defect.
A new study suggests a link between abdominal obesity and an increased risk of colon cancer, with waist circumference and waist-to-hip ratio being key factors. Additionally, incidence rates of ocular non-Hodgkin lymphoma have been rising rapidly, with no signs of slowing down.
A large population-based study found that long-term smokers who never used NSAIDs had the highest risk of colon cancer. Smokers using NSAIDs still faced a 30% higher risk than nonsmokers. The study suggests NSAIDs may not counteract smoking's adverse effects on colorectal-cancer risk.
A new approach to lymph node examination, called targeted lymph node examination, has been shown to improve staging of colon cancer. This technique uses blue dye to identify the sentinel node, which is the first node to receive lymphatic drainage from a primary tumor site.
Researchers at OHSU Cancer Institute analyzed data from 5,587 colon cancer subjects to determine five-year conditional survival rates. The study found that as time elapsed since diagnosis, most subjects experienced an improvement in their subsequent five-year conditional survival following the initial disease-free period.
Computed Tomographic Colonography (CTC) screening found extra-colonic abnormalities in approximately 16 percent of asymptomatic patients. The most common findings were coronary artery calcifications and non-calcified pulmonary nodules. CTC was also compared to optical colonoscopy (OC) for detecting polyps, with comparable accuracy in i...
A novel colonoscope using the NeoGuide System reduces looping and discomfort during colonoscopies, while entonox sedation provides effective pain relief and faster recovery. These advancements increase rates of colorectal cancer screening and improve patient satisfaction.
Researchers found that ACE inhibitor use was associated with a 55% risk reduction for esophageal cancer, a 48% reduced risk of pancreatic cancer, and a 47% reduced risk of colon cancer. The studies suggest that ACE inhibitors may play a valuable role in advancing current treatment options for multiple cancers.
A novel stool testing technique has been developed, showing high sensitivity (88%) in detecting colon cancer. The new test is more sensitive than previous versions, making it easier to perform and potentially leading to better patient outcomes.
A study published in Carcinogenesis reveals that sulforaphane, a compound in broccoli and cauliflower, can inhibit the development of hereditary colon cancer by inducing apoptosis and inhibiting tumor proliferation. The researchers found that mice fed with an SFN-supplemented diet developed significantly fewer and smaller tumors.
A new study analyzed data from 3,193 stage III colon cancer patients and found that 78.2% completed adjuvant chemotherapy treatment. Incomplete treatment was linked to physical frailty, treatment complications, and lack of social support.